January 15, 2021 at 6:53 am

200K and Counting

More than 200K people have viewed our two akathisia videos, and MISSD is pleased that a third akathisia video is now in production. Please see and share these public health videos to increase awareness and reduce akathisia-induced deaths.


January 13, 2021 at 8:05 am

Jimi Hendrix’s Final Days

Prescription sleeping pills, agitation, insomnia, facial swelling, and flu-like symptoms preceded Jimi Hendrix’s death, notes Tony Brown, author of Jimi Hendrix: The Final Days.

“Jimi doesn’t look particularly healthy in these photographs: his face seems a little puffy and on only a few of the pictures does he attempt to smile,” said Brown.

Hendrix, whose death in 1970 was not ruled a suicide, had been taking the prescription drug, Vesperax, for insomnia.

Read the full article at https://rare.us/people/jimi-hendrix-death/

January 11, 2021 at 4:04 pm

Some Antibiotics can Cause Psychiatric “Side Effects”

Some commonly prescribed antibiotics, including doxycycline, can cause suicidality and other psychiatric adverse effects but the patient information leaflets still lack carefully worded warnings that can better protect consumers and reduce avoidable suffering and deaths.

Read the full article at https://www.irishnews.com/lifestyle/2021/01/07/news/how-some-antibiotics-may-trigger-mental-breakdowns-2177260/

January 4, 2021 at 1:40 pm

Akathisia in the News

It’s good to see akathisia in the news and also very important to note that akathisia can cause psychiatric symptoms. The presence of akathisia often leads “physicians to inappropriately increase agents such as selective serotonin reuptake inhibitors (SSRIs)…”

The cause of akathisia must first be identified, and initial treatment must be directed at that cause. Read the full article at https://www.gilmorehealth.com/akathisia-latest-facts-risk-factors-symptoms-and-treatment/

December 17, 2020 at 2:40 pm

Meditation Can Reduce Stress & Has No Risk of Adverse Drug Effects

A recent Growth Spurts program featured MISSD Founder Wendy Dolin, who discussed the benefits of meditation as a tool to reduce stress and anxiety during challenging times. See: https://www.youtube.com/watch?v=hxpcKvnhvxo&t=149s

December 10, 2020 at 4:05 pm

Quieting the Silence

We’ve received great feedback from last night’s collaborative program, “Quieting the Silence: Suicide Awareness in the Jewish Community,” and want to thank The Blue Dove Foundation, No Shame on U, and JCFS Chicago for helping make this meaningful event possible.

Listen at: https://www.facebook.com/missd.co/videos/1566440863635684

December 7, 2020 at 1:47 pm

Meditation During Challenging Times

“Growth Spurts,” a program sponsored by the Full-Bloomed Lotus-Center for Self Awareness, will interview MISSD Founder, Wendy Dolin on Dec. 10th at 2 p.m. Central Time. Dolin will discuss the mission of MISSD, and ways meditation can help during challenging times. See: https://www.fullbloomedlotus.com/soul

Tune in at: https://us02web.zoom.us/j/85722072135…

Zoom Meeting ID: 857 2207 2135 Passcode: 412798

December 4, 2020 at 5:24 am

The BJGP, a leading primary care research journal, has published an important letter about misdiagnosis of antidepressant dependence and withdrawal. We appreciate the efforts of authors Marion Brown and Stevie Lewis to increase awareness of adverse drug effects that can cause suicidality and suicide.

They write, “Most urgently, we urge individual prescribers to always raise with their patients possibilities such as antidepressant adverse effects and/or potential dose-change and withdrawal issues before initially prescribing an antidepressant for any patient – and before attributing patients’ subsequent development of ‘unexplained’ ‘functional’ symptoms to psychosomatic ‘medically unexplained’ or ‘functional’ syndromes and disorders.”

Read the full article at: https://bjgplife.com/2020/12/03/the-patient-voice-antidepressant-withdrawal-mus-and-fnd/

December 1, 2020 at 2:40 pm

MISSD’s Akathisia Campaign Reaches California Commuters

It’s Giving Tuesday, and MISSD wants to give a big shout out to all who help us reduce avoidable suffering and death by increasing akathisia awareness.

Today in San Francisco, commuters and tourists can see our mass transit ads on buses and inside terminals. This ad campaign was made possible by the generosity of supporters dedicated to reducing the 4th leading cause of death: Adverse drug effects.

“Nobody is immune to medication harms, and adverse drug effects don’t discriminate,” said MISSD Founder, Wendy Dolin.

The MISSD Akathisia Awareness Campaign reaches the West Coast. Previous akathisia ads were featured in New York City and Chicago.

Read the article at https://www.einpresswire.com/article/531844116/prescription-drugs-can-cause-suicidality-and-suicide

November 24, 2020 at 8:55 am

Can IA Reduce Veterans’ Deaths?

“For more than a decade, health officials have watched in vain as suicide rates climbed steadily — by 30 percent nationally since 2000 — and rates in the V.A. system have been higher than in the general population. The trends have defied easy explanation and driven investment in blind analysis: machine learning, or A.I.-assisted algorithms that search medical and other records for patterns historically associated with suicides or attempts in large clinical populations.”

MISSD also hopes the VA will closely examine the role polypharmacy plays in medication-induced suicide among veterans.

Read the full article https://www.nytimes.com/2020/11/23/health/artificial-intelligence-veterans-suicide.html?action=click&module=Well&pgtype=Homepage&section=Health